Susanna Stanfield


Susanna is a partner in the corporate team.

She joined the firm from JAG Shaw Baker when they merged with Withers to create a new legal offering, Withers tech, in 2018.

Susanna has more than 20 years’ experience as a corporate and venture capital lawyer. Susanna specialises in advising both high-growth companies and investors in the life sciences and technology sectors. In particular, Susanna heads the Cambridge office and acts for a number of Cambridge-based companies to help them commercialise their scientific discoveries or technology.

Over the years, Susanna has been actively involved with the British Private Venture Capital Association (BVCA) and its publication of model investment documents.

Track record





Represented Medovate Limited, a vehicle established to enable the commercialisation of intellectual property generated from NHS Trusts in East Anglia.

Company counsel for a number of drug discovery companies based in Cambridge who are backed by venture capital investors and advises them in respect of their funding rounds, day to day general corporate and restructuring requirements.

Involved in the commercialisation of technology from research institutions such as the University of Cambridge and Imperial Innovations representing founders and the spin out companies as well as investors in this process.

Canada, 1998

England and Wales, 1999

Co-author of the BVCA model documents and drafting notes

BVCA working committee

Key participant of the 2015 industry review of the BVCA model documents and was responsible for the drafting these revised BVCA model document

Provided several presentations about key issues facing early stage companies seeking venture capital investment.



  • English